Literature DB >> 750271

Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil.

S Fujii, K Ikenaka, M Fukushima, T Shirasaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 750271

Source DB:  PubMed          Journal:  Gan        ISSN： 0016-450X


× No keyword cloud information.
  42 in total

1.  Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule.

Authors:  R Pazdur; Y Lassere; E Diaz-Canton; B Bready; D H Ho
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

2.  Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with L-cystine.

Authors:  M Iigo; A Hoshi; H Kitagawa
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  Elevation of plasma levels of fluorinated pyrimidines by guanosine 5'-monophosphate.

Authors:  M Iigo; Z Yamaizumi; S Nishimura; A Hoshi
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay.

Authors:  M Nishiyama; S Takagami; Y Kirihara; T Saeki; N Hirabayashi; Y Nosoh; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1988-11

5.  Changes in folate concentration in Yoshida sarcoma after administration of leucovorin or cisplatin.

Authors:  K Omura; T Misaki; T Hashimoto; E Kanehira; T Watanabe; F Ishida; Y Watanabe; T Shirasaka
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

6.  Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.

Authors:  Masanori Terashima; Hisataka Fujiwara; Akinori Takagane; Kaoru Abe; Takashi Irinoda; Tsutomu Nakaya; Hitoshi Yonezawa; Kenichi Oyama; Kazuyoshi Saito; Norio Kanzaki; Satoshi Ohtani; Tsuyoshi Nemoto; Yutaka Hoshino; Michihiko Kogure; Mitsukazu Gotoh
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

7.  Multicentre phase II study of leucovorin plus pharmacokinetic modulating chemotherapy for metastatic colorectal cancer.

Authors:  Yasuhiro Inoue; Koji Tanaka; Junichiro Hiro; Yuji Toiyama; Chikao Miki; Masato Kusunoki
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

8.  Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.

Authors:  M Iigo; A Hoshi
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests.

Authors:  M Nishiyama; K Niimi; S Takagami; N Hirabayashi; M Yamaguchi; T Saeki; K Yoshinaka; D C Wang; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1988-01

10.  Report on nationwide pooled data and cohort investigation in UFT phase II study.

Authors:  K Ota; T Taguchi; K Kimura
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.